AI Article Synopsis

  • - HSK21542 is a new drug targeting kappa opioid receptors, tested for safety and effectiveness through two parts of a study involving healthy volunteers with varying doses and infusion durations.
  • - The drug showed a clear dose-response relationship and was quickly eliminated from the body with most of it excreted unchanged in urine, while also increasing prolactin levels.
  • - Overall, HSK21542 was well tolerated, with mostly mild side effects like paresthesia, indicating potential for treating pain and itching without serious adverse events.

Article Abstract

HSK21542 injection is a new peripheral kappa opioid receptor (KOR) agonist. To evaluate its safety, tolerability, pharmacokinetics and pharmacodynamics, this study was conducted in healthy volunteers, consisting of two parts: a single ascending dose (0.2-3.375 μg/kg, 15-min infusion) and different infusion durations (0.2 and 1 μg/kg, 2- or 15-min infusion). The area under the plasma concentration-time curve (AUC) and peak concentration (C) of HSK21542 were dose-linear among 0.2-3.375 μg/kg. After intravenous injection, HSK21542 was rapidly eliminated with a half-life (t) of 1.5 h, and the majority (48.02%) of the dose was excreted unchanged in urine. Pharmacodynamic results showed that HSK21542 increased prolactin release and reached a peak at 1-2 h after administration but had no significant effect on vasopressin levels. There was a brief increase in urine volume within the initial 2 h after administration. HSK21542 was well tolerated; most of the adverse effects (AEs) in the trial group were grade 1, and only 2 cases (4.0%) were grade 2. The main AE was paresthesia, which appeared in 42% (21/50) in the trial group. No serious adverse event (SAE) was observed. No subject withdrew early due to AEs. These results suggest that HSK21542 may be a potential treatment for pain and pruritic conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.14094DOI Listing

Publication Analysis

Top Keywords

pharmacokinetics pharmacodynamics
8
hsk21542 injection
8
healthy volunteers
8
15-min infusion
8
trial group
8
hsk21542
7
phase clinical
4
clinical trial
4
trial evaluating
4
evaluating safety
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!